| 前收市價 | 275.60 |
| 開市 | 275.27 |
| 買盤 | 265.80 x 1200 |
| 賣出價 | 279.93 x 3000 |
| 今日波幅 | 274.91 - 279.77 |
| 52 週波幅 | 261.59 - 473.50 |
| 成交量 | |
| 平均成交量 | 205,214 |
| 市值 | 7.89B |
| Beta 值 (5 年，每月) | 0.88 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -21.83 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 409.80 |
ZacksNew Strong Sell Stocks for April 19th
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
ZacksBio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
ZacksBio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.
